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ABSTRACT  Treatment of epithelial African green monkey kidney (BSC-1) cells with the potent 
tumor promoter  12-O-tetradecanoylphorbol-13-acetate  (TPA) induces a rapid and  reversible 
redistribution of actin and vinculin that is detectable after only 2 min of treatment. Within 20- 
40 min,  stress fibers disappear, while at the same time large actin-containing  ribbons resem- 
bling  ruffles  develop  both  at  the  cell  periphery  and  in  more  central  regions.  Vinculin  is 
associated  with these actin ribbons or bands in a punctate or patchy staining pattern. Adhesion 
to the  substratum  is changed  from  predominantly  focal  contacts  associated  with stress fiber 
ends  in  untreated  cells  to  broad  zones  of  close  contact  after TPA treatment.  High  voltage 
electron  microscopic  observations  disclose  the ribbons to consist  of highly cross-linked  actin 
filament  networks.  Thus,  an  association  of vinculin  with  filament  networks,  rather than  (the 
ends  of)  filament  bundles,  is  demonstrated.  The  integrity  of  microtubules  and  vimentin 
filaments  is  not affected  by TPA treatment,  but their distribution  is altered  to conform  with 
the  highly  distorted  cell  shape.  The  response  to TPA  is  neither  prevented  nor  modified  by 
nocodazole-induced  depolymerization  or  taxol-induced  stabilization  of  microtubules.  An 
intact  intermediate  filament  network  seems  not  required  either  since  colcemid-induced 
collapse of vimentin  filaments towards the nucleus does not affect the cell's response  to TPA. 
Rapid  redistribution  of  actin  and  vinculin  also  takes  place  in  enucleated  cells  and  in  the 
presence  of cycloheximide,  but  is  prevented  by  dinitrophenol  or oligomycin.  TPA-induced 
cytoskeletal alterations are independent of fibronectin expression and not mimicked, modified, 
or prevented  by calmodulin  inhibitors or experimentally elevated  levels of calcium and cyclic 
AMP.  Thus  the  morphological  response  to  TPA  involves  rapid  redistribution  of  actin  and 
vinculin  independent  of transcription  and translation,  fluctuations  in the levels  of calcium  or 
cyclic  AMP,  or  changes  in  the  organization  of  microtubules,  intermediate  filaments,  and 
fibronectin. 
Tumor promoters  are  molecules  that  are  not  carcinogenic 
themselves  but  that  are  able  to  increase  the  incidence  of 
tumors in tissues pretreated with a  carcinogenic agent (for a 
recent  review,  see  reference  1).  The  most  effective  tumor 
promoter is 12-O-tetradecanoylphorbol- 13-acetate (TPA [also 
known as phorbol myristate acetate]), ~ a  macrocyclic diter- 
Abbreviations used in this paper: PHEM, 60 mM PIPES, 25 mM 
HEPES, 8 mM EGTA, 2 mM MgCI2;  TPA, 12-O-tetradecanoylphor- 
bol-13-acetate; BSC-1, African green monkey kidney cells; PtKI, rat 
kangaroo cells. 
pene ester extracted from the seeds of Croton tiglium (2).  It 
has been shown that TPA and related tumor-promoting phor- 
bol esters have profound effects on cultured cells even without 
pretreatment by a carcinogenic agent. In many respects, these 
effects resemble those induced by transforming viruses. They 
include alterations in cell morphology (3),  loss of fibronectin 
from the cell surface (4), stimulation of plasminogen activator 
production  (5),  increase  in  the  rate  of sugar  transport  (3), 
stimulation  of cell  growth  (6),  and  induction  of ornithine 
decarboxylase (7).  Because  of the substantial  overlap in the 
activities  of tumor  promoters  and  oncogenic  viruses  (e.g., 
THE JOURNAL OF  CELL BIOLOGY - VOLUME 99 SEPTEMBER 1984 1045-1059 
© The Rockefeller University Press . 0021-9525/84/09/1045/15  $1.00  1 045 Rous sarcoma virus), it is hoped that the elucidation of the 
mechanism of action of the tumor promoters may also shed 
some light on the process of virus-induced transformation. 
The  precise  mechanism of action  of tumor promoters  is 
not yet understood. It has been determined that phorbol esters 
bind to  particulate preparations of chick embryo fibroblasts 
in a  specific, saturable manner (8,  9).  At least one of these 
binding sites  co-purifies  with  protein  kinase  C,  the  Ca  ÷+- 
activated, phospholipid-dependent protein kinase (10-12). In 
accordance with this observation, several groups have noted 
changes in the pattern of protein phosphorylation after treat- 
ment with phorbol esters ( 13-16). However, the role of protein 
phosphorylation in the cascade of physiological and biochem- 
ical  changes  following treatment  of cells  with  tumor  pro- 
moters remains to be elucidated. 
Tumor promoter-induced changes of the cytoskeleton have 
not been the subject of intensive research. Many studies just 
note an "altered morphology" that seems to resemble that of 
transformed cells (17-20). However, the observed changes in 
cell morphology were only occasionally studied with respect 
to specific structural and physiological alterations in the cy- 
toskeleton. Conflicting observations as to the requirement of 
RNA and protein synthesis (18,  20,  21) or the involvement 
of plasminogen activator (17, 20) were not resolved. 
This  study  analyzes  morphological  changes  induced  by 
TPA in cultured cells, primarily African green monkey kidney 
cells  (BSC-1),  and  attempts  to  determine  the  cytoskeletal 
target(s)  and  erector(s).  TPA-induced cytoskeletal  changes 
are extremely rapid,  first signs being detectable after only 2 
min as a reorganization of filamentous actin and the adhesion 
plaque protein, vinculin. This reorganization is independent 
of transcription or translation and microtubule or intermedi- 
ate filament organization, but dependent on metabolic energy, 
and is neither mimicked nor prevented by experimental ele- 
vation of intracellular calcium or cyclic AMP, or by calmod- 
ulin inhibitors. Thus reorganization of actin and vinculin and 
subsequent changes in cell  morphology seem to be brought 
about by specific events affecting actin and/or the  proteins 
with which it interacts. 
MATERIALS  AND  METHODS 
Cell Culture:  Several  cell types were used in these studies, including 
African green monkey kidney cells (strain BSC-I), rat kangaroo cells (PtK1), 
3T3 fibroblasts,  mouse 10T1 cells,  and normal rat kidney cells, but this report 
will be confined to the results obtained with BSC and PtK cells. Qualitatively 
similar results were obtained with the other cell types employed,  even  though 
their response  to the various  experimental  treatments may differ  in detail. BSC- 
l cells  were grown in Dulbecco's  modified  Eagle  medium (Gibeo Laboratories, 
Grand Island, NY) supplemented  with 10% fetal calf serum. PtK1 cells  (kindly 
provided by Dr. W. Z. Cande)  were  grown  in Fl 2 medium (Gibeo  Laboratories). 
Immunofluorescence Microscopy:  Theprotocolfor fluorescence 
microscopy used in most of the experiments comprised fixation with 0.5% 
glutaraldehyde in PHEM (22) buffer (60 mM PIPES, 25 mM HEPES, 8 mM 
EGTA, 2 mM MgC12)  supplemented  with 0.1% Triton X-100 for 10 min (see 
also reference  23), after which  the cells  were washed  three times  with phosphate- 
buffered saline (PBS). They were then treated with 1% sodium borohydride  in 
PBS (24), washed again, and reacted with either rhodamine phalloidin (25) 
alone, or a combination of rhodamine phalloidin and an antibody against 
mammalian tubulin, vinculin, fibronectin (Transformation Research, Inc., 
Framingham, MA), or vimentin, The cells  were washed again, and incubated 
with the appropriate fluoresceinated  second antibodies. Variations  of the fixa- 
tion protocol included glutaraldehyde  alone followed by treatment with 0.1% 
Triton X-100 in PBS, pre-extraction  with 0.1% Triton X-100 in PHEM buffer 
(22) followed by glutaraldehyde  fixation, or fixation with 0.15% formalin in 
PHEM buffer. Essentially  the same results were obtained with these fixation 
schemes. Coverslips  were then mounted in 90% glycerol/10%  PBS containing 
0. 1% p-phenylene-diamine  and viewed  in a Zeiss  Photomicroscope Ill. 
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High Voltage Electron Microscopy:  For  high voltage electron 
microscopy, cells were grown on gold grids and processed according to a 
protocol outlined earlier (22). Briefly,  cells  were extracted with 0.1% Triton X- 
100 in PHEM buffer, fixed  with 1% glutaraldehyde  in PHEM for 10 min, and 
postfixed with osmium tetroxide (0.5%) for 3 min. Some preparations were 
reacted with heavy meromyosin-subfragment  1 (kindly provided by Dr. Frank 
Pepe) before fixation.  Preparations  were then dehydrated with ethanol, critical 
point-dried, and viewed in the Boulder high voltage electron microscope at 
1,000 kV. 
Enuclea Lion:  For enucleation,  cells  were  grown  on 12-mm  round cover- 
slips, inserted cell-side down in a round-bottom centrifuge tube containing 
culture medium supplemented with 10 ug/ml cytochalasin B, and spun at 
12,000 g for 40-50 min in a Sorvall  centrifuge  (DuPont Co., Wilmington,  DE). 
Cytoplasts on coverslips  were thoroughly washed with culture medium and 
used for further experiments  within 2-4 h. The enucleation rate usually was 
85-95%. 
Chemicals:  Nocodazole,  cycloheximide,  dinitrophenol, oligomycin,  2- 
deoxyglucose, TPA, cytochalasin  B, dibutyryl-cyclic  AMP, isobutylmethylxan- 
thine, and A23187 were all obtained from Sigma Chemical Co. (St. Louis, 
MO). 
Taxol was a kind gift of Dr. Douros (Natural Products Branch, National 
Cancer Institute). Trifluoperazine  was obtained from Smith, Kline & French, 
Inc. (Philadelphia,  PA). Calmidazolium  was a kind gift of Dr. Marc de Braban- 
der (Janssen Pharmaceutica,  Beerse, Belgium). 
RESULTS 
All  experiments  were  performed  over  a  broad  time  scale 
ranging from  1  min to  2  d  and over a  wide  range of TPA 
concentrations (0.1-1,000 ng/ml). For the sake of clarity and 
brevity, data for the first hour of TPA treatment at a concen- 
tration of 50 ng/ml will be presented. It should be mentioned 
at the outset that the inactive phorbol derivates, 4-c~-phorbol 
and 4-a-phorbol  12,13-didecanoate did not show any of the 
effects described here for TPA. 
Time Course 
Treatment of exponentially growing BSC-1  cells with TPA 
at  50 ng/ml promotes a  rapid and dramatic change of their 
overall morphology (Fig.  1). The normally rounded or polyg- 
onal cells adopt an irregular outline with many lamellar, filar, 
or  knobby  protrusions  at  their  periphery.  In  areas  of the 
culture  dish  in  which  cells  had  formed  confluent patches, 
confluency is disrupted and large gaps develop in which the 
ragged  cell peripheries recede  from  one another.  This mor- 
phological transformation is completed by 30-40 min and is 
maintained for as long as the promoter is present. 
The  organization  of actin  following TPA  treatment  was 
examined by means of fluorescence  microscopy  using rho- 
damine-labeled phalloidin which binds specifically to filamen- 
tous actin (25).  Untreated  BSC-1  cells contain a  prominent 
system of filament bundles or stress fibers that are associated 
with the substrate-apposed cell side (Fig. 2a).  No prominent 
staining is revealed in the cell periphery, a  finding consistent 
with the observation that BSC-I  cells possess only relatively 
small peripheral ruffles (22). Very shortly after TPA is added 
to the culture medium, changes in actin filament organization 
are  perceived.  Within 2  min  staining in  the  cell  periphery 
begins to intensify and so continues for the following 20-40 
min,  leading to  the  formation  of what  appear  to  be  huge 
ruffles  (Fig.  2,  b-f).  In  addition,  similar  actin-containing 
protuberances of crescent-shaped or circular appearance de- 
velop  more  centrally.  With  time  both  the  peripheral  and 
central actin whorls become so brilliant that they dominate 
the fluorescent image and make photographic recording dif- 
ficult.  The  process  of their  formation  is  surprisingly rapid; 
many are well developed by 8  min. By 30 min, they are the FIGURE  I  Phase-contrast  micrographs  of  BSC-1  ceils  during TPA 
treatment. (a) Untreated; (b) 40 ng/ml TPA for 20 min; (c) 40 ng/ml 
TPA for 40 min. x  400. 
single  most  prominent  actin-containing  structure  of most 
cells. 
While actin whorls are being formed, the stress fiber system 
disappears.  This  process is  also  gradual  and  overlaps with 
ruffle formation so that  for the  first 20-30  min  most cells 
display both structures--the former continually increasing in 
number and density, the latter waning. Stress fibers disappear 
in a process of gradual thinning, rather than abrupt breaking 
or  unravelling.  Virtually  all  filament  bundles  have  disap- 
peared by 40-50 min. 
The  effects of TPA  are  completely reversible.  Recovery 
proceeds as an almost exact reversion of the original reorgan- 
ization, only that it takes much longer. Normal cell morphol- 
ogy is restored after 7-10 h. 
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Correlation with Vinculin Organization 
To examine whether this  rapid  and  profound change  in 
actin distribution  is accompanied by changes in the organi- 
zation of vinculin (26, 27), we stained cells with antibodies to 
mammalian vinculin and rhodamine-phalloidin using stand- 
ard double-labeling immunofluorescence techniques.  As ex- 
pected, antibody to vinculin intensely stains the ends of stress 
fibers in untreated cells (Fig. 3 a). The dimensions of vinculin- 
containing patches vary considerably, but  roughly correlate 
with the size of the associated stress fibers. Vinculin staining 
is observed exclusively at the ends of stress fibers;  no periph- 
eral staining is evident.  TPA treatment leads to a  dramatic 
redistribution of vinculin that is precisely correlated with the 
redistribution of actin. Vinculin staining after TPA treatment 
falls into three categories: (a) granular, amorphous, or patchy 
staining associated with peripheral and central actin ruffles, 
(b) staining associated with stress fiber ends, and (c) staining 
of "adhesion junctions." 
(a)  Soon  after peripheral or  central  ruffle-like structures 
appear, vinculin is found associated with them as faint and 
rather indistinct accumulations of small patches. These rap- 
idly grow in size,  number, and intensity as the actin ribbons 
grow larger. Only within the first few minutes of TPA treat- 
ment  are  examples  of actin-containing  ruffles  found  that 
apparently do not have any vinculin staining associated with 
them.  Thus,  it  is  possible that,  at  least in  some instances, 
vinculin  associates with  pre-formed actin-containing struc- 
tures. We were unable to find any evidence for the formation 
of  granular vinculin patches before actin associates with them. 
(b) With respect to vinculin's association with stress fiber 
ends, there is again a strict correlation. As long as stress fibers 
persist in TPA-treated cells, and some cells still possess stress 
fibers after 30-40 min of  treatment with TPA, there is vinculin 
present at their ends. Occasionally stress fiber-associated vin- 
culin patches are found where most of the actin bundle has 
already disappeared, except for a small patch that co-localizes 
with the remaining vinculin (Fig.  3, c and d). The identifica- 
tion of these patches as stress fiber-associated is suggested by 
their characteristic spearhead shape. Once all stress fibers have 
disassembled, the vinculin staining formerly associated with 
their ends also disappears. 
(c) An  unusual  staining pattern that is observed in  ~10- 
20% of the TPA-treated cells appears at sites where neighbor- 
ing cells are in contact. These sites are characterized by a co- 
localization of actin and  vinculin,  the  former as a  band of 
intense staining, the latter along two parallel lines separated 
by an  unstained  gap (Fig.  4a).  Similar structures  in  Rous 
sarcoma virus-transformed cells are termed adhesion junc- 
tions by Shriver and  Rohrschneider  (28),  and  this  term  is 
adopted here. Typically such junctions extend for ~ 10-30 #m 
along the cell margins, but occasionally they reach the dimen- 
sions of the junction shown in Fig. 4, a and b. Most interest- 
ingly, however, such junctional staining patterns are not only 
observed between cells, but also within cells in regions where 
no contact with a neighboring cell exists. Such "self-junctions" 
may appear as  invaginations  of a  peripheral junction  (not 
shown), or, as in Fig. 4,  c and d, they may be present in the 
cell center with no connection to the periphery. Characteristi- 
cally the  trilaminar vinculin  staining  is accompanied by a 
broad actin ribbon. 
All three forms of vinculin staining--stress fiber-associated 
feet, ruffle-associated patches or ribbons, and adhesion or self- 
junctions--are found at the substrate-associated cell side,  as 
El AL.  Tumor Promoter-induced  Actin and Vinculin  Reorganization  1047 FIGURE  2  BSC-1 cells  stained  with 
rhodamin-phalloidin  during  TPA 
treatment. (a)  Untreated. Treatment 
with  40  ng/ml TPA  for 2  rain  (b).  8 
min  (c).  15  min  (d).  30  min  (e).  60 
min (f). x  400. 
demonstrated by careful through-focusing. This would mean 
that both the peripheral and central actin whorls must extend 
through the thickness of  the cell in order for them to maintain 
an  association  with  vinculin  at  the  substrate  face  of the 
membrane.  That this is the case is suggested by experiments 
in which cells are disrupted with a buffer jet that removes the 
bulk of the cell body and leaves behind only substrate-asso- 
ciated cellular components. As shown in Fig. 4, e and f, the 
association of actin with vinculin and of both with the sub- 
stratum is strong enough to survive this treatment (cf.  refer- 
ence 29). 
Substrate Contact 
The fact that the modified vinculin staining in TPA-treated 
cells is  found on the substratum-associated cell side (Fig.  4) 
may suggest a congruence with substrate adhesion zones. To 
test this, we viewed control and TPA-treated cells with reflec- 
tion interference-contrast optics (Fig. 5). Whereas stress fibers 
of untreated cells terminate in dark focal adhesions which, in 
turn,  coincide  with  vinculin  feet,  adhesion  sites  of TPA- 
treated cells are mostly broad zones of grey close contacts that 
include,  but  are  not restricted  to,  the  prominent  actin  and 
1048  THE  JOURNAL  OF  CELL BIOLOGY • VOLUME  99,  1984 
vinculin ribbons.  Occasionally, cells are found whose entire 
ventral surface consists of a close-contact zone, even though 
ruffles and vinculin ribbons are confined to the cell periphery. 
Therefore,  contact  to  the  substratum  is  largely  uncoupled 
from the distribution  of actin and vinculin after TPA treat- 
ment. 
High Voltage Electron Microscopy 
To determine changes in filament organization at the ultra- 
structural level, we used high voltage electron microscopy of 
detergent-extracted whole mount preparations. The transition 
from an epithelial morphology with a smooth cell outline to 
a highly distorted cell shape is reflected in the distribution of 
the cell's filamentous components. Stereo pairs clearly show 
many of the salient features of the changes in filament orga- 
nization induced by TPA (Fig. 6).  Extensive peripheral  net- 
works of very high filament density resembling ruffled regions 
of other cell  types (e.g.,  neutrophils;  see reference 30) domi- 
nate  the  cytoskeleton.  The  overwhelming  majority  of the 
filaments contained in these structures is F-actin, as demon- 
strated by heavy meromyosin-subfragment 1 decoration. Sim- 
ilar regions of high filament density are found in more central FIGURE  3  BSC-1 cells double-labeled with antibodies against vinculin (a, c, and e) and rhodamin-phalloidin (b, d, and f). (a and 
b)  Untreated.  (c and  d) Treatment with  40  nglml TPA  for  15  min.  (e  and  f)  Treatment with  40  ngJml TPA  for  30  min.  Note 
appearance of  peripheral and  central  actin  ribbons (arrows) in d  and  f which  are associated with  bands of punctate  vinculin 
staining (c and e), and coexistence of stress fibers and ribbons in d. x  400. 
cell areas (not shown); in size and shape they clearly resemble 
the crescent or ring-shaped actin ribbons detected by fluores- 
cence  microscopy.  Unlike  peripheral  ruffle-like  networks, 
however, these central filament masses do not protrude exten- 
sively from the cell surface. 
A second striking feature ofTPA cytoskeletons is an overall 
decrease in filament density throughout most of the cell body 
except in  ruffled networks. Indications of this alteration are 
easily perceived by comparing the two stereo pairs presented 
in Fig. 6.  Examination of many stereo pairs clearly indicates 
that  this  decrease in  filament  network  density  is  due  to  a 
decrease in the number of actin filaments, in agreement with 
the fluorescence microscopic observations. Coupled with the 
observation  of a  high  actin  filament density  in  peripheral 
networks,  this  suggests that  the  net  result  of TPA-induced 
cytoskeletal rearrangements is a shift of actin filaments from 
the cell body and stress fibers into cortical networks, with a 
concomitant loss of normal cell morphology. 
Between 15 and 30 min after addition of TPA, when stress 
fibers are dismantled,  many of them  are  associated with a 
cloud of filaments near one  or both ends (Fig.  7a),  which 
give the filament bundle a "bouquet" look. The clouds consist 
of highly cross-linked networks of actin filaments, as shown 
by decoration  with  heavy meromyosin-subfragment  1.  In- 
spection at higher magnification (Fig. 7 b) reveals the presence 
of many structural interactions between the  major filamen- 
tous components of the cytoskeleton (22).  Such interactions 
are  mediated  by  2-3-nm  filament  linkers  and  end-to-side 
contacts of actin  filaments with  other actin  filaments (Fig. 
7b),  microtubules, and intermediate filaments (not shown). 
Although quantification is difficult, analysis of many micro- 
graphs suggests  neither a dramatic increase nor a decrease in 
SCHLIWA ET AL.  Tumor  Promoter-induced Actin and Vinculin Reorganization  1049 FIGURE  4  (a and b) Large "adhesion junction" between two neighboring cells stained with rhodamine-phalloidin (a) and vinculin 
(b). x  600. (Insets  to a and b) Higher magnifications of part of the junctional complex. TPA treatment was for 60 min at 40 ng/ml. 
x  1,200. (c and d) Adhesion "self" junctions in the center of a BSC-1 cell, stained with phalloidin in c and vinculin antibodies in 
d. 30-min TPA treatment. Note trilaminar appearance of vinculin  staining (arrows). x  1,500. (e and f)  Residues of actin ribbons 
after the cell body was sheared away with a buffer jet. (e) Phalloidin staining, (f) Vinculin staining. Note remnant of an "adhesion 
junction" (arrow). x  1,500. 
any of these structural features compared to untreated cells. 
Rather, their spatial distribution is altered in such a way that 
they are more abundant in some regions of the cytoskeleton 
than  in  others.  For  example,  2-3-nm  filaments  are  more 
frequent  in  the  vicinity  of dense  actin  networks  (Fig.  7). 
Outside these areas, actin filaments can be followed for longer 
distances than in untreated cells, suggesting that the free path 
length  between  intersections  formed with  cross-linking ele- 
ments is increased. 
Microtubules and Intermediate Filaments 
A  series  of experiments was  devoted  to  the  question  of 
whether the other two major filamentous components of the 
cytoskeleton,  microtubules and  intermediate  filaments,  are 
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affected by TPA treatment, and to what extent, if at all, they 
are  involved  in  the  morphological  TPA  response.  Double 
labeling with antibodies against tubulin and rhodamine phal- 
loidin  show  that  the  astral  microtubule array of untreated 
cells (see reference 22) is still intact but distorted to conform 
with  the  irregular cell  shape (Fig.  8,  a-c).  To test whether 
microtubule integrity  or assembly/disassembly are required 
for TPA-induced cytoskeletal reorganization, we exposed cells 
to nocodazole (2 ug/ml for 1-2 h) or taxol (4 ug/ml for 6-20 
h). While the former compound rapidly depolymerizes micro- 
tubules, the latter promotes microtubule assembly and leads 
to the formation of stable, occasionally bizarre, microtubule 
arrays throughout the cell body (31-33).  Neither of the two 
drugs significantly affects actin or vinculin organization and FIGURE  5  Phase-contrast (a  and 
d), rhodamine-phalloidin staining 
(b and e), and reflection interfer- 
ence-contrast microscopy (c and 
f) of an untreated (a-c) BSC-1 cell 
and a cell treated with 40  ng/ml 
TPA for 30 min (d-f). Dark strands 
of focal adhesions associated with 
the ends of stress fibers in control 
cells  are  replaced  by  extensive 
zones of gray mottled appearance 
indicative  of  close  contacts. 
These gray areas include, but are 
not  restricted  to  (see  areas 
marked  by  asterisks  in  e  and  f), 
the peripheral ribbons of staining 
to  which  actin  and  vinculin  are 
confined.  Arrowheads  indicate 
streaks of black focal contacts as- 
sociated  with  remnants  of  fila- 
ment bundles, x  400. 
cell shape; only prolonged treatment (> 15 h) leads to a slight 
decrease in the number of stress fibers. When nocodazole or 
taxol-treated cells are exposed to TPA, both the time course 
and the  final  state  of actin  and  vinculin  reorganization are 
identical to that of cells treated with TPA alone (Fig. 8, d-f 
and  g-i).  Thus  these  experiments  do  not  suggest  a  direct 
involvement of microtubules in TPA-induced morphological 
transformations. 
Like  microtubules,  BSC-1  intermediate  filaments,  which 
are of the vimentin type (22), remain intact after TPA treat- 
ment (not shown). Their possible involvement is more diffi- 
cult to assess,  since no experimental treatment is known that 
selectively affects this filament class.  However, by treating live 
cells with microtubule inhibitors for longer time periods, it is 
at least possible to influence their distribution within the cell. 
If BSC- 1 cells are kept in the presence of 2 #g/ml nocodazole 
for  24  h,  intermediate  filaments  collapse  towards  the  cell 
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center and coil up in the vicinity of the nucleus while the cells 
still  maintain  a  spread  epithelial  morphology.  Subsequent 
treatment with  TPA promotes the same characteristic actin 
and vinculin reorganization as in control cells (Fig. 9), arguing 
against the  involvement  of an  intact  intermediate  filament 
network in this response. 
Fibronectin 
Tumor promoters induce loss of fibronectin from the cell 
surface (4).  Since cytoskeleton and cell shape are influenced 
by the level of fibronectin (34), an obvious question to ask is 
whether  the  alterations  in  actin  and  vinculin  organization 
observed here are related to, or even induced by, changes in 
surface-associated  fibronectin.  Using  an  antibody  directed 
against  fibronectin,  very little  fibronectin  was  found to  be 
associated  with  BSC-1  cells,  in  agreement  with  an  earlier 
report (35). Thus, changes in fibronectin organization are not 
ET AL.  Tumor  Promoter-induced  Actin and Vinculin Reorganization  1051 FIGURE  6  Stereo pairs  of  deter- 
gent-extracted control cell (a) and 
a cell treated with TPA for 30 min 
(b).  A  peripheral  region  most 
probably corresponding to an ac- 
tin ribbon is disclosed as a dense 
filament network with a ruffle-like 
appearance.  The  residual  fiber 
network throughout the cell body 
appear  significantly  more  open 
than in control cells, x  5,000. 
involved in the morphological TPA response of BSC-1 cells. 
To test whether fibronectin changes might occur in a cell type 
that expresses this  surface glycoprotein, we used  PtK1  cells 
which lay down a dense fibronectin carpet (Fig.  10, a and b). 
Exposure  of PtK1  cells  to  TPA  at  the  same  concentration 
used  in  BSC-1  cells  induces  a  similar  series  of dramatic 
cytoskeletal changes that affect both actin and vinculin (Fig. 
10, e and f), but not the overall organization of fibronectin 
(Fig. 10, c and d). However. we cannot exclude the possibility 
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that fibronectin fibers located at, and closely associated with, 
the cell surface might be altered. 
Transcription, Translation, and Metabolic Energy 
In agreement with an earlier report (21) that demonstrates 
that TPA does not require the nucleus to induce morpholog- 
ical changes as seen  by phase-contrast microscopy, we  find 
that enucleated BSC-1 cells undergo the same series of  changes 
in actin and vinculin organization over the same time period FIGURE  7  Stereo  pairs of part of 
a BSC-1  cell treated  with TPA for 
20 min. The short filament bundle 
in  a,  probably  a  remnant  of  a 
stress  fiber,  is  associated  with  a 
dense  filament  network  com- 
posed  mainly  of actin  filaments. 
This  preparation  was  decorated 
with  heavy  meromyosin-subfrag- 
ment 1 before fixation, x  18,000. 
(b) higher magnification of part of 
a, demonstrating the presence of 
all  major  filamentous  compo- 
nents,  including  microtubules 
(large  arrows),  heavy  mero- 
myosin-subfragment  1  -labeled 
actin filaments (small arrows), in- 
termediate filaments  (double ar- 
rows), and 2-3  nm filament link- 
ers (arrowheads). x  68,000. 
as intact cells (not shown). Similarly, pretreatment of either 
intact or enucleated cells with the protein synthesis inhibitor, 
cycloheximide (10 ~g/ml  for  1 h),  followed by TPA  in the 
presence of the inhibitor, fails to inhibit the reorganization of 
actin and vinculin. In contrast, pretreatment with dinitrophe- 
nol (0.5  mg/ml)  or oligomycin (1  ug/ml) in the presence of 
2-deoxyglucose (1 mg/ml) in glucose-free medium completely 
blocks morphological changes and actin or vinculin reorgan- 
ization  (not  shown).  From  these  experiments  we  conclude 
that TPA-induced morphological changes occur independent 
of transcription and translation, but require metabolic energy. 
Cyclic AMP, Calcium, and Calmodulin 
Tumor  promoters  have  been  shown  to  influence  cAMP 
levels and metabolism (e.g., references  36,  37);  other studies 
SCHLIWA ET AL.  Tumor Promoter-induced  Actin and Vinculin  Reorganization  1053 link tumor promoters to calcium fluxes (e.g., references 38- 
41) and calmodulin (e.g., references 42, 43). Both cAMP and 
calcium play a basic role in cellular metabolism, particularly 
with respect to protein phosphorylation, and at least some 
of the effects of TPA on cells may involve changes in phos- 
phorylation (12-15).  While  studies  on cytoskeleton-related 
FIGURE  8  Microtubules in TPA-treated BSC-1 ceils. Phase contrast (a, d, and g), staining with antibody against tubulin (b, e, and 
h), and rhodamin-phalloidin (c, f, and i). (a-c) 40 min TPA alone. (d-f)  Pretreatment with 2 pg/ml nocodazole for 1.2 h, followed 
by TPA treatment in the  presence of the drug. Most  microtubules are depolymerized, except for a few presumably associated 
with the centrosome (arrow). (g-i)  Pretreatment with 4  p,  gJml taxol for 15 h, followed by TPA treatment in the presence of the 
drug. The radial microtubule array is replaced by tufts and networks of microtubule pieces, x  400. 
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way, we have sought to clarify whether changes in cAMP and 
calcium levels can enhance, mimick, or inhibit TPA-induced 
cytoskeletal alterations. 
BSC-1 cells treated with 1 mM dibutyryl-cAMP for 6-20 h 
in the presence of isobutyl methylxanthine, a phosphodiester- 
ase inhibitor, show minor changes in overall cell morphology, 
including a slightly more irregular outline and condensed and 
branched stress fibers (Fig.  11 a). Vinculin is characteristically 
concentrated at stress fiber ends (Fig.  11 b). However, cAMP/ 
isobutyl methylxanthine pretreatment completely fails to in- 
hibit or modify the series of changes in both actin and vinculin 
organization induced by TPA (Fig.  1  l, c and d). In a similar 
set  of experiments,  cells  were  exposed  to  the  calmodulin 
inhibitors, calmidazolium (2.5  and 5 uM) or trifluoperazine 
( 10 and 40 uM), for 1-3 h at concentrations known effectively 
to inhibit calmodulin (44,  45).  While causing minor changes 
in actin organization when used alone (stress fibers are more 
abundant  and  appear  "frizzy;"  see  Fig.  12a),  the  typical 
response to TPA is not inhibited (Fig.  12, b and c). In another 
set of experiments, the calcium ionophore A23187  (2.5  ug/ 
ml  for  2-7  h,  with  1  mM  calcium  added  to  the  culture 
medium),  while  promoting  minor  changes  in  stress  fiber 
organization when used alone (Fig.  12 d), does not inhibit or 
enhance TPA-induced  stress fiber dissolution,  formation of 
actin ribbons, and reorganization of vinculin (Fig.  12, e and 
f). 
DISCUSSION 
We have analyzed the  changes induced  by a  potent tumor 
promoter in  the  organization  of the  three  major  filament 
systems  and  the  adhesion  plaque  protein,  vinculin.  TPA 
promotes a  rapid and reversible reorganization of actin and 
vinculin. The integrity of microtubules and intermediate fil- 
aments is not affected, even though their distribution changes 
to conform with the highly distorted cell  shape. In speed of 
action and  the degree of distortion  of cellular morphology, 
these cytoskeletal changes are comparable to those induced 
by the cytochalasins (46-48).  In contrast to previous sugges- 
tions, we find that TPA-induced cytoskeletal rearrangements 
are independent of intact microtubule and intermediate fila- 
ment networks since they are not prevented by nocodazole 
depolymerization or taxol  stabilization  of microtubules,  or 
nocodazole-induced collapse of intermediate filaments. A di- 
rect involvement of either microtubules or intermediate fila- 
ments therefore seems unlikely. 
Contrary to the findings of one group (18), but in agreement 
with reports by others (20,  21),  transcription and translation 
are not required for the morphological response. Thus changes 
in  the  pattern  of protein  synthesis  reported  to  occur after 
administration  of TPA  (e.g.,  references  5,  7,  13,  49-51), 
including that of cytoskeletal proteins (52),  are unrelated to 
the morphological events studied here. However, the change 
in  morphology  is  actively  induced  by  the  cell  since  it  is 
suppressed by inhibitors of energy metabolism. 
The rapid and dramatic reorganization of actin and vincu- 
lin occurs in a  highly coordinated fashion and involves two 
seemingly independent but overlapping processes: (a) disman- 
tling of stress fibers and associated adhesion plaques, and (b) 
development of actin  networks with newly-formed vinculin 
ribbons. The light microscopic appearance of  the new vinculin 
sites is distinctly different from that of plaques at stress fiber 
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FIGURE  9  Cell treated with 2 ~g/ml nocodazole for 24 h, followed 
by TPA for 40 min. Double labeling was with rhodamine-phalloidin 
(a) and an antibody against vimentin (b). Despite collapse of inter- 
mediate filaments  towards  the  nucleus,  the  characteristic actin 
rearrangement still occurs,  x  400. 
ends  in  that  it  is  punctate,  dotted,  or  diffuse,  rather  than 
triangular and sharply delineated. The appearance of the new 
sites is reminiscent of the vinculin patches or rosettes in Rous 
sarcoma virus-transformed cells (28,  53,  54).  A relationship 
to  the  transient  vinculin  "belts"  in  EGTA-treated  Madin- 
Darby canine kidney cells (55) may also exist.  Thus a change 
in the organization of vinculin is an additional  feature that 
TPA  shares  with  transforming  viruses.  Yet  another  corre- 
spondence between the effects of tumor promoters and trans- 
forming viruses concerns the  induction  of "adhesion junc- 
tions" that contain actin and vinculin and, in Rous sarcoma 
virus-transformed cells, the product of the transforming gene, 
pp60 src (28).  Such junctions typically display vinculin stain- 
ing in two parallel bands separated by an unstained cleft (Fig. 
3 b). It is interesting that staining with similar characteristics 
is found not only between cells,  but also within cells,  in an 
appearance analogous to that of intracellular or "selr'-junc- 
tions described for certain pathological conditions or special- 
ized tissues (e.g., references 56, 57). As in peripheral vinculin 
ribbons, actin is associated with these self-junctions as well. 
The co-distribution of vinculin and actin-containing ruffle- 
like cellular domains represents a novel and unusual form of 
association between these two cytoskeletal components. To 
our  knowledge,  vinculin  patches  underlying  ruffled  mem- 
brane regions have not  been  noted  in  any other cell  type. 
Coupled with the high voltage electron microscopic observa- 
tion  that  TPA-induced  actin  ribbons  consist  of extensive 
three-dimensional networks ofactin filaments, this constitutes 
the  first observation of vinculin  association with  actin  net- 
works, rather than (the ends of) actin bundles.  This form of 
ET  AL.  Tumor Promoter-induced Actin and Vinculin  Reorganization  1055 FIGURE  10  PtK1 cells stained with  rhodamine-phalloidin (a, c, and e), antibodies against fibronectin  (b and d), and antibodies 
against vinculin  (f).  Untreated  cells  exhibit a  prominent  system  of  stress  fibers traversing the  cells  (a) and  a  thick  carpet  of 
substrate-associated fibronectin (b). TPA treatment at 40 ng/ml for 40 min induces a dramatic reorganization of actin (c),  but no 
apparent change in fibronectin (d). Note how the fibronectin carpet in (d) still seems to reflect the morphology and organization 
of the cells before TPA  treatment, but now distorted in response to the compound (c).  The reorganization of actin in  PtK1 cells 
induced by TPA is accompanied by a corresponding change in the distribution of vinculin (e and f). Note the correspondence of 
a central actin ring (e) with a similar ring of punctate and patchy vinculin staining (f). x  400. 
association  is  consistent  with  in  vitro  observations of low 
affinity binding  sites  for vinculin  along actin  filaments,  in 
addition to high affinity sites believed to be localized at the 
growing filament ends (58,  59). However, the in vitro associ- 
ation of vinculin along the length of actin filaments leads to 
the formation of actin bundles, rather than three-dimensional 
networks (59, 60). Therefore, the precise mode of interaction 
between  vinculin  and  actin  within  TPA-induced  networks 
observed here requires further study. 
A  question  of particular  interest  concerns  the  temporal 
relationship between the redistribution of actin and the reor- 
ganization  of vinculin.  On  the  basis  of the  characteristic 
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association of vinculin with the termini of stress fibers and 
the congruence of these termini with adhesion plaques, it is 
tempting to speculate that perturbance of vinculin organiza- 
tion might be related to both the dissolution of stress fibers 
and the loss of adhesive properties, two prominent features of 
transformed cells. With respect to stress fiber dissolution, this 
proposal might also be extended  to  TPA-treated cells.  If it 
were  possible  to  demonstrate  that  vinculin  reorganization 
precedes actin redistribution, it would be entirely consistent 
with this proposal and would constitute strong indirect evi- 
dence  in  its  favor.  However,  careful  analysis  of our  time 
course studies on double-labeled cells  does not  corroborate FIGURE 11
￿
BSC-1 cells treated with 1 mM dibutyryl CAMP plus 1 mM isobutylmethylxanthine for 20 h. While causing a minor
but clearly perceptible distortion of normal cell morphology and stress fiber organization (a), this treatment does not affect the
characteristic association of vinculin with stress fiber ends (b) . In contrast, subsequent treatment with TPA for 40 min still induces
the rapid, dramatic rearrangements of both actin (c) and vinculin (d) . x 400 .
this view . Vinculin is present at the termini of stress fibers up
to the point of their dissolution ; in fact, if anything, vinculin
plaques are the last to go (Fig . 3, c and d) . Conversely, the
formation of TPA-induced vinculin patches and ribbons has
not been found to precede the development of actin networks ;
again, at early time points the reverse is more likely. Thus,
on a time scale of minutes or even seconds, actin ribbons and
stress fibers are not found without corresponding vinculin
patches. The view that changes in vinculin plaques precede
actin changes (29, 61) or that vinculin serves as organization
sites for the formation of actin bundles (62) is not supported
by these experiments . It needs to be considered, however, that
vinculin within adhesion plaques might be altered in more
subtle ways, leading to effects on actin organization without,
at first, corresponding changes in vinculin localization .
What might be the nature of the alterations that affect
vinculin? Vinculin is a phosphoprotein with phosphorylation
sites at serine, threonine, and tyrosine (63) . Accordingly, the
level of phosphorylation was considered as a possible regula-
tory event. This view was strengthened by the observation
that in transformed cells, vinculin is "overphosphorylated" at
tyrosine (64), and that this biochemical change is accom-
panied by loss ofadhesion plaques (53, 54) . However, tyrosine
phosphorylation as an event leading to stress fiber dissolution
has later been questioned on the basis of experiments with
partial transformation mutants of Rous sarcoma virus that
induce tyrosine phosphorylation but allow cells to retain stress
fibers terminating in vinculin plaques (65). Further, phospho-
tyrosine is not increased before mitosis when cells dismantle
SCHLIWA ET AL .
stress fibers (66) . On the other hand, vinculin has recently
been shown in vitro to be a substrate for protein kinase C,
the phospholipid-dependent kinase specific for serine and
threonine residues (63). This finding is of particular interest
since protein kinase C has been shown to be activated by TPA
(12, 67, 68 ; however, see also reference 16) . While studies on
possible changes in phosphorylation of cytoskeletal proteins
after TPA treatment did not yet yield conclusive results, we
show here that cytoskeletal alterations are neither prevented
nor mimicked by calmodulin inhibitors or elevated calcium
or cAMP, factors known to be involved in phosphorylation-
dependent activation of cellular functions. Thus, whether a
single-step event involving altered phosphorylation of vincu-
lin can explain the changes in vinculin and actin distribution
observed here remains to be demonstrated . These changes are
of dual nature, involving dissociation of actin and vinculin in
preexisting plaques and a new form of association in ribbons.
Whether vinculin in these newly-formed sites possesses altered
properties requires further study.
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